- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 843748, 8 pages
Comparative Analyses of the β-Tubulin Gene and Molecular Modeling Reveal Molecular Insight into the Colchicine Resistance in Kinetoplastids Organisms
1Laboratorio de Bioquímica y Biología Molecular de Parásitos, Instituto de Biología Experimental (IBE), Facultad de Ciencias, Universidad Central de Venezuela (UCV), Caracas 1041A, Venezuela
2Unidad de Química Medicinal, Facultad de Farmacia, Universidad Central de Venezuela, Caracas 1041A, Venezuela
3Laboratorio de Inmunoparasitología, Centro de Microbiología, Instituto Venezolano de Investigaciones Científicas (IVIC), Caracas 1020A, Venezuela
Received 29 April 2013; Accepted 16 July 2013
Academic Editor: Georgios Theodoropoulos
Copyright © 2013 Luis Luis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- WHO, “Control of the leishmaniasis,” WHO Technical Report Series, WHO, Geneva, Switzerland, 2010.
- A. Mendoza-León, J. J. Shaw, and F. J. Tapia, “A guide for the cutaneous leishmaniasis connoisseur,” in Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis, F. J. Tapia, G. Cáceres-Dittmar, and M. A. Sánchez, Eds., pp. 1–23, R.G. Landes Company Biomedical Publishers, Austin, Tex, USA, 1996.
- S. L. Croft, S. Sundar, and A. H. Fairlamb, “Drug resistance in leishmaniasis,” Clinical Microbiology Reviews, vol. 19, no. 1, pp. 111–126, 2006.
- S. Sundar, F. Rosenkaimer, M. K. Makharia et al., “Trial of oral miltefosine for visceral leishmaniasis,” The Lancet, vol. 352, no. 9143, pp. 1821–1823, 1998.
- X. Serrano-Martín, G. Payares, M. De Lucca, J. C. Martinez, A. Mendoza-León, and G. Benaim, “Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 12, pp. 5108–5113, 2009.
- M. Kavallaris, “Microtubules and resistance to tubulin-binding agents,” Nature Reviews Cancer, vol. 10, no. 3, pp. 194–204, 2010.
- B. J. Fennell, J. A. Naughton, J. Barlow et al., “Microtubules as antiparasitic drug targets,” Expert Opinion on Drug Discovery, vol. 3, no. 5, pp. 501–518, 2008.
- A. P. Jackson, S. Vaughan, and K. Gull, “Comparative genomics and concerted evolution of β-tubulin paralogs in Leishmania spp,” BMC Genomics, vol. 7, p. 137, 2006.
- L. Luis, A. Ramírez, C. M. Aguilar, S. Eresh, D. C. Barker, and A. Mendoza-León, “The genomic fingerprinting of the coding region of the β-tubulin gene in Leishmania identification,” Acta Tropica, vol. 69, no. 3, pp. 193–204, 1998.
- A. Mendoza-León and D. C. Barker, “Variation of a multigene family in New World Leishmania: the β-tubulin gene region,” in Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis, F. J. Tapia, G. Cáceres-Dittmar, and M. A. Sánchez, Eds., pp. 107–128, R.G. Landes Company Biomedical Publishers, Austin, Tex, USA, 1996.
- A. Mendoza-León, L. Luis, and C. Martinez, “The β-tubulin gene region as a molecular marker to distinguish Leishmania parasites,” in Methods in Molecular Biology. Gene Probes Principles and Protocols, M. Aquino de Muro and R. Rapley, Eds., vol. 179, pp. 61–83, Humana Press, Totowa, NJ, USA, 2002.
- C. Délye, Y. Menchari, S. Michel, and H. Darmency, “Molecular bases for sensitivity to tubulin-binding herbicides in green foxtail,” Plant Physiology, vol. 136, no. 4, pp. 3920–3932, 2004.
- K. A. Werbovetz, D. L. Sackett, D. Delfín et al., “Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites,” Molecular Pharmacology, vol. 64, no. 6, pp. 1325–1333, 2003.
- K. A. Werbovetz, J. J. Brendle, and D. L. Sackett, “Purification, characterization, and drug susceptibility of tubulin from Leishmania,” Molecular and Biochemical Parasitology, vol. 98, no. 1, pp. 53–65, 1999.
- K. A. Werbovetz and R. E. Morgan, “Selective lead compounds against kinetoplastid tubulin,” Advances in Experimental Medicine and Biology, vol. 625, pp. 33–47, 2008.
- T. H. Macrae and K. Gull, “Purification and assembly in vitro of tubulin from Trypanosoma brucei brucei,” Biochemical Journal, vol. 265, no. 1, pp. 87–93, 1990.
- A. J. Yakovich, F. L. Ragone, J. D. Alfonzo, D. L. Sackett, and K. A. Werbovetz, “Leishmania tarentolae: purification and characterization of tubulin and its suitability for antileishmanial drug screening,” Experimental Parasitology, vol. 114, no. 4, pp. 289–296, 2006.
- K. Gull, “The cytoskeleton of trypanosomatid parasites,” Annual Review of Microbiology, vol. 53, pp. 629–655, 1999.
- R. Bai, D. G. Covell, X. Pei et al., “Mapping the binding site of colchicinoids on β-tubulin: 2-chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354,” Journal of Biological Chemistry, vol. 275, no. 51, pp. 40443–40452, 2000.
- S. Uppuluri, L. Knipling, D. L. Sackett, and J. Wolff, “Localization of the colchicine-binding site of tubulin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 11598–11602, 1993.
- K. H. Downing, “Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics,” Annual Review of Cell and Developmental Biology, vol. 16, pp. 89–111, 2000.
- E. Nogales, S. G. Wolf, and K. H. Downing, “Structure of the αβ tubulin dimer by electron crystallography,” Nature, vol. 391, no. 6663, pp. 199–203, 1998.
- R. B. G. Ravelli, B. Gigant, P. A. Curmi et al., “Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain,” Nature, vol. 428, no. 6979, pp. 198–202, 2004.
- A. Mendoza-Leon, J. C. Havercroft, and D. C. Barker, “The RFLP analysis of the β-tubulin gene region in New World Leishmania,” Parasitology, vol. 111, no. 1, pp. 1–9, 1995.
- P. C. Ng and S. Henikoff, “SIFT: predicting amino acid changes that affect protein function,” Nucleic Acids Research, vol. 31, no. 13, pp. 3812–3814, 2003.
- P. C. Ng and S. Henikoff, “Predicting the effects of amino acid substitutions on protein function,” Annual Review of Genomics and Human Genetics, vol. 7, pp. 61–80, 2006.
- T. Xi, I. M. Jones, and H. W. Mohrenweiser, “Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function,” Genomics, vol. 83, no. 6, pp. 970–979, 2004.
- B. Gigant, C. Wang, R. B. G. Ravelli et al., “Structural basis for the regulation of tubulin by vinblastine,” Nature, vol. 435, no. 7041, pp. 519–522, 2005.
- T. Schwede, J. Kopp, N. Guex, and M. C. Peitsch, “SWISS-MODEL: an automated protein homology-modeling server,” Nucleic Acids Research, vol. 31, no. 13, pp. 3381–3385, 2003.
- N. Guex and M. C. Peitsch, “SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling,” Electrophoresis, vol. 18, no. 15, pp. 2714–2723, 1997.
- J. C. Phillips, R. Braun, W. Wang et al., “Scalable molecular dynamics with NAMD,” Journal of Computational Chemistry, vol. 26, no. 16, pp. 1781–1802, 2005.
- A. Pedretti, L. Villa, and G. Vistoli, “VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming,” Journal of Computer-Aided Molecular Design, vol. 18, no. 3, pp. 167–173, 2004.
- M. Wiederstein and M. J. Sippl, “ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins,” Nucleic acids research, vol. 35, pp. W407–W410, 2007.
- R. A. Laskowski, M. W. MacArthur, D. S. Moss, and J. M. Thornton, “PROCHECK-a program to check the stereochemical quality of protein structures,” Journal of Applied Crystallography, vol. 26, pp. 283–291, 1993.
- S.-Q. Li, M.-C. Fung, S. A. Reid, N. Inoue, and Z.-R. Lun, “Immunization with recombinant β-tubulin from Trypanosoma evansi induced protection against T. evansi, T. equiperdum and T. b. brucei infection in mice,” Parasite Immunology, vol. 29, no. 4, pp. 191–199, 2007.
- A. Massarotti, A. Coluccia, R. Silvestri, G. Sorba, and A. Brancale, “The tubulin colchicine domain: a molecular modeling perspective,” ChemMedChem, vol. 7, no. 1, pp. 33–42, 2012.
- F. L. Henriquez, P. R. Ingram, S. P. Muench, D. W. Rice, and C. W. Roberts, “Molecular basis for resistance of Acanthamoeba tubulins to all major classes of antitubulin compounds,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 3, pp. 1133–1135, 2008.
- Y. Lu, J. Chen, M. Xiao, W. Li, and D. D. Miller, “An overview of tubulin inhibitors that interact with the colchicine binding site,” Pharmaceutical Research, vol. 29, no. 11, pp. 2943–2971, 2012.
- K. Chen, J. T. Huzil, H. Freedman et al., “Identification of tubulin drug binding sites and prediction of relative differences in binding affinities to tubulin isotypes using digital signal processing,” Journal of Molecular Graphics and Modelling, vol. 27, no. 4, pp. 497–505, 2008.
- C. H. A. Cheung, S.-Y. Wu, T.-R. Lee et al., “Cancer cells acquire mitotic drug resistance properties through β I-tubulin mutations and alterations in the expression of β-tubulin isotypes,” PloS one, vol. 5, no. 9, p. e12564, 2010.
- C. Stengel, S. P. Newman, M. P. Leese, B. V. L. Potter, M. J. Reed, and A. Purohit, “Class III Β-tubulin expression and in vitro resistance to microtubule targeting agents,” British Journal of Cancer, vol. 102, no. 2, pp. 316–324, 2010.